NAVB
Navidea Biopharmaceuticals Inc.
NAVB
NAVB
Delisted
NAVB was delisted on the 5th of October, 2023.
82 hedge funds and large institutions have $79.4M invested in Navidea Biopharmaceuticals Inc. in 2015 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 19 increasing their positions, 23 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
38% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 13
97% less call options, than puts
Call options by funds: $286K | Put options by funds: $9.75M
Holders
82
Holding in Top 10
1
Calls
$286K
Puts
$9.75M
Top Buyers
| 1 | +$4.97M | |
| 2 | +$1.58M | |
| 3 | +$916K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$482K |
| 5 |
State Street
Boston,
Massachusetts
|
+$223K |
Top Sellers
| 1 | -$5.01M | |
| 2 | -$933K | |
| 3 | -$381K | |
| 4 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$216K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$178K |